Deadline extended for GAMRIF C-CAMP AMR challenge 2024-2025
3 months ago

Deadline extended for GAMRIF C-CAMP AMR challenge 2024-2025

The Hindu  

The Centre for Cellular and Molecular Platforms has extended the application deadline for the GAMRIF C-CAMP AMR challenge 2024-2025 till September 22. The Global AMR Innovation Fund is a U.K. One Health aid fund that supports Research and Development around the world to reduce the threat of Antimicrobial Resistance in humans, animals and the environment for the benefit of people in Low and Middle Income Countries. C-CAMP has partnered with the U.K. Department of Health and Social Care’s GAMRIF to nurture and fund innovations for antimicrobial resistance in the environment with special focus on LMICs. The GAMRIF C-CAMP AMR challenge is catered towards identifying mid-to late-stage innovators working in the field of AMR in the Environment and will provide them with grant, deployment, and mentoring opportunities.

Amr  environment  innovations  health  resistance  deadline  gamrif  challenge  ccamp  uk  20242025  fund  extended  amr

History of this topic

Indo-Dutch-Swiss tripartite agreement inked to address challenges posed by Antimicrobial Resistance
1 year, 1 month ago

Indo-Dutch-Swiss tripartite agreement inked to address challenges posed by Antimicrobial Resistance

The Hindu  

The Centre for Cellular and Molecular Platforms has announced a next-generation tripartite Indo-European collaboration to address the challenges posed by Antimicrobial Resistance, with science, innovation, policy, and stewardship. “This tripartite agreement welcomes a new entrant, Swissnex in India, the Swiss science and technology consulate part of a Swiss global network connecting Switzerland and the world in education, research, and innovation, …

Putting minds and funds together to find ways of tackling drug resistance
1 year, 5 months ago

Putting minds and funds together to find ways of tackling drug resistance

The Hindu  

Recently, in a hospital in the Indian city of Hyderabad, a patient in the ICU was realy ill with an extensive drug resistant bacterial infection. Abdul Ghafur, infectious diseases specialist, and one of the authors of the Chennai Declaration, a joint medical community effort to handle antimicrobial resistance in the country, says the precedent set by the COVID-19 pandemic and …

Discover Related